You are a smart man...
After FDA reject approve the ARDS even going against 9x1 because MSB could not prove tech how the drug works or some consistent performance..if i were you i will be not be so safe that ,yes, all pharmas are in queue trying to buy the secondary endpoint achieved,mainly because highly likely will need new trials new money, more time etc...
At that stage my view is MSB failure and will be a LONG LONG way to recover one cent confidence of market...
Amazing deals ?
wells that always can happen, is not that the best bait of desperation holders ?
CATO
Let's just get this done at $10 per MSB share, page-5
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.5¢ |
Change
-0.005(0.52%) |
Mkt cap ! $1.090B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | 97.0¢ | 95.0¢ | $339.0K | 354.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 18865 | 95.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 96.0¢ | 58800 | 18 |
View Market Depth
| Last trade - 10.57am 13/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |